Thymosin α1 is a 28-residue synthetic peptide widely characterised in published immunomodulatory in-vitro research.
Thymosin α1 is a 28-residue N-acetylated synthetic peptide corresponding to a fragment of prothymosin α. Published research literature focuses on TLR-mediated immune-cell signalling in in-vitro models.
- Batch identifier and synthesis date traceable to the lot record
- HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
- LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
- Counterion identity and content (acetate or trifluoroacetate) reported
- Bacterial endotoxin and residual solvents per the analytical method
Research use only. All information on this page is provided strictly for in-vitro and laboratory research reference. Nothing in this article is medical, therapeutic, dosing, or performance advice for human or veterinary use.
